Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR

Perry Michael S sold 11,600 Arrowhead Pharmaceuticals, Inc. shares (Form 4)

Traded Aug 18, 2026 · Filed Aug 20, 2026

On Aug 18, 2026, Perry Michael S (Director) sold 11,600 Arrowhead Pharmaceuticals, Inc. shares at US$87.30 for US$1.01M, leaving 111,459 shares. Filed Aug 20, 2026 (Form 4).

Sold
11,600 shares
Price
US$87.30
Value
US$1.01M
Holding after
111,459 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 18, 2026Common StockSale11,600US$87.30111,459Direct

Source

View original at SEC

Related